BioScience Health Innovations, Inc. (formerly NowTransit Inc.) reported significant financial growth in its latest 10-Q filing for the third quarter of 2025. The company generated revenues of $1.13 million for the three months ending September 30, 2025, a 97% increase from $573,000 in the same period last year. For the nine months ended September 30, 2025, revenues reached $4.12 million, compared to $1.23 million for the same period in 2024. Despite this revenue growth, the company reported a net loss of $8,782 for the third quarter, contrasting with a net income of $56,202 in the prior year. However, the nine-month net income showed a substantial increase to $875,720 from $77,043 in 2024.
The financial performance reflects a strategic shift following the acquisition of Best 365 Labs Inc. in March 2023, which has allowed BioScience to expand its product offerings in the health and wellness sector. The company has introduced several products, including Be On-Guard Mouth Spray and Be On-Guard Nasal Spray, which have contributed to increased sales. Additionally, the company has made significant investments in marketing and operational capabilities, leading to higher operating expenses of $707,000 for the third quarter, up from $369,000 in the previous year.
Operationally, BioScience has seen a notable increase in its asset base, with total assets rising to $2.07 million as of September 30, 2025, compared to $874,000 at the end of 2024. This growth is primarily attributed to a substantial increase in inventory, which rose to $758,000 from $58,000, and cash and cash equivalents, which increased to $1.14 million from $663,000. The company’s total liabilities also increased significantly, primarily due to advances from related parties, which totaled $2.42 million for the nine months ended September 30, 2025.
Looking ahead, BioScience Health Innovations is focused on expanding its market presence and product offerings. The company has filed for multiple patents related to its innovative delivery systems, which are expected to provide a competitive edge in the health and wellness market. Management has expressed optimism about the potential for growth in various therapeutic areas, including mental health and metabolic health, and is actively seeking additional funding to support its operations and strategic initiatives. However, the company acknowledges that its ability to continue as a going concern is contingent upon successfully implementing its business plan and securing adequate financing.
About BioScience Health Innovations, Inc.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.